Innovations in ventricular tachycardia ablation
- PMID: 35879516
- DOI: 10.1007/s10840-022-01311-z
Innovations in ventricular tachycardia ablation
Abstract
Catheter ablation of ventricular arrhythmias (VAs) has evolved significantly over the past decade and is currently a well-established therapeutic option. Technological advances and improved understanding of VA mechanisms have led to tremendous innovations in VA ablation. The purpose of this review article is to provide an overview of current innovations in VA ablation. Mapping techniques, such as ultra-high density mapping, isochronal late activation mapping, and ripple mapping, have provided improved arrhythmogenic substrate delineation and potential procedural success while limiting duration of ablation procedure and potential hemodynamic compromise. Besides, more advanced mapping and ablation techniques such as epicardial and intramyocardial ablation approaches have allowed operators to more precisely target arrhythmogenic substrate. Moreover, advances in alternate energy sources, such as electroporation, as well as stereotactic radiation therapy have been proposed to be effective and safe. New catheters, such as the lattice and the saline-enhanced radiofrequency catheters, have been designed to provide deeper and more durable tissue ablation lesions compared to conventional catheters. Contact force optimization and baseline impedance modulation are important tools to optimize VT radiofrequency ablation and improve procedural success. Furthermore, advances in cardiac imaging, specifically cardiac MRI, have great potential in identifying arrhythmogenic substrate and evaluating ablation success. Overall, VA ablation has undergone significant advances over the past years. Innovations in VA mapping techniques, alternate energy source, new catheters, and utilization of cardiac imaging have great potential to improve overall procedural safety, hemodynamic stability, and procedural success.
Keywords: Catheter ablation; Innovation; Stereotactic radiation therapy; VT mapping; Ventricular arrhythmia; Ventricular tachycardia.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, et al. HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2019;17(1):e2–e154. https://doi.org/10.1016/j.hrthm.2019.03.002 . - DOI - PubMed - PMC
-
- Willems S, Tilz RR, Steven D, Kääb S, Wegscheider K, Gellér L, et al. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients with Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): a multicenter randomized trial. Circulation. 2020;141(13):1057–67. https://doi.org/10.1161/CIRCULATIONAHA.119.043400 . - DOI - PubMed
-
- Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357(26):2657–65. https://doi.org/10.1056/NEJMoa065457 . - DOI - PubMed - PMC
-
- Ravi V, Poudyal A, Khanal S, Khalil C, Vij A, Sanders D, et al. A systematic review and meta-analysis comparing radiofrequency catheter ablation with medical therapy for ventricular tachycardia in patients with ischemic and non-ischemic cardiomyopathies. J Interv Cardiac Electrophysiol: An Int J Arrhythmias Pac. 2022. https://doi.org/10.1007/s10840-022-01287-w .
-
- Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375(2):111–21. https://doi.org/10.1056/NEJMoa1513614 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
